Association of the anti-inflammatory activity of phosphodiesterase 4 (PDE4) inhibitors with either inhibition of PDE4 catalytic activity or competition for [3H]rolipram binding-Reference-Cited by-同舟云学术

Association of the anti-inflammatory activity of phosphodiesterase 4 (PDE4) inhibitors with either inhibition of PDE4 catalytic activity or competition for [3H]rolipram binding

Published:1996-04 Issue:7 Volume:51 Page:949-956
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Bamette Mary S.,Bartus Joan O'Leary,Burman Miriam,Christensen Siegfried B.,Cieslinski Lenora B.,Esser Klaus M.,Prabhakar Uma S.,Rush Julia A.,Torphy Theodore J.

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference34 articles.

1. The granulocyte responses to the phosphodiesterase inhibitor RO 20-1724;Busse;J Allergy Clin Immunol,1981

2. Interaction of formylmethionylleucyl-phenylalanine, adenosine and phosphodiesterase inhibitors in human monocytes;Elliott;FEBS Lett,1989

3. Effects of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst;Nielson;J Allergy Clin Immunol,1990

4. Preliminary identification and role of phosphodiesterase isozymes in human basophils;Peachell;J Immunol,1992

5. Inhibition of CD44, CD45, and LFA-3 mediated cytokine release from human monocytes by SK&F 86002 and pentoxifylline;Prabhakar;Int J Immunopharmacol,1993

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Molecular Biology of Phosphodiesterase 4 Enzymes as Pharmacological Targets: An Interplay of Isoforms, Conformational States, and Inhibitors;Pharmacological Reviews;2021-07

2. Current and Emerging Therapies in Chronic Obstructive Pulmonary Disease;Burger's Medicinal Chemistry and Drug Discovery;2021-04-26

3. Phosphodiesterase inhibitors say NO to Alzheimer's disease;Food and Chemical Toxicology;2019-12

4. Heterocycle Synthesis through Pd-Catalyzed Carbonylative Coupling;European Journal of Organic Chemistry;2019-05-31

5. Computational Approaches in the Development of Phosphodiesterase Inhibitors;Quantitative Structure-activity Relationship;2017-08-30